NDC product
Phenobarbital Oral Solution
NDC 54288-163 · BPI Labs LLC
Key facts
| Product NDC | 54288-163 |
|---|---|
| Proprietary name | Phenobarbital Oral Solution |
| Nonproprietary name | Phenobarbital Oral |
| Substances | PHENOBARBITAL |
| Dosage form | SOLUTION |
| Route | ORAL |
| Labeler | BPI Labs LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| DEA schedule | CIV |
| Marketing start | Oct 27, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: